Home
About
Overview
Sharing Data
ORCID
Help
History (75)
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients.
Systematic analysis of sigma54 N-terminal sequences identifies regions involved in positive and negative regulation of transcription.
Mesocolon
Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response.
Molecular genetics of attention deficit hyperactivity disorder.
See All 75 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular genetics of attention deficit hyperactivity disorder.
Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 2010 Mar; 33(1):159-80.
View in:
PubMed
subject areas
Attention Deficit Disorder with Hyperactivity
Gene Expression
Genome-Wide Association Study
Humans
Molecular Biology
Prevalence
Twins
authors with profiles
Eric O Mick ScD